Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia

Tsuang, 1979, Long-term outcome of major psychoses, I: schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions, Arch Gen Psychiatry, 36, 1295, 10.1001/archpsyc.1979.01780120025002 Bleuler, 1968, A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia, 3 Ciompi, 1980, Catamnestic long-term study on the course of life and aging of schizophrenics, Schizophr Bull, 6, 606, 10.1093/schbul/6.4.606 Harvey, 1999, Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients, Biol Psychiatry, 45, 32, 10.1016/S0006-3223(98)00273-X Davidson, 1996, Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease, Am J Psychiatry, 153, 1274, 10.1176/ajp.153.10.1274 Arnold, 1995, Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients, Am J Psychiatry, 152, 731, 10.1176/ajp.152.5.731 Arnold, 1998, Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia, Arch Gen Psychiatry, 55, 225, 10.1001/archpsyc.55.3.225 Harrison, 1999, The neuropathology of schizophrenia: a critical review of the data and their interpretation, Brain, 122, 593, 10.1093/brain/122.4.593 Damadzic, 2001, A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder, and major depression: absence of significant astrocytosis, Brain Res Bull, 55, 611, 10.1016/S0361-9230(01)00529-9 Walker, 2002, Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia, Am J Psychiatry, 159, 821, 10.1176/appi.ajp.159.5.821 Thune, 2001, No deficit in total number of neurons in the prefrontal cortex in schizophrenics, J Psychiatr Res, 35, 15, 10.1016/S0022-3956(00)00043-1 Calabrese, 2000, NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance, Neurochem Res, 25, 1315, 10.1023/A:1007604414773 Sayre, 2001, Chemistry and biochemistry of oxidative stress in neurodegenerative disease, Curr Med Chem, 8, 721, 10.2174/0929867013372922 Wallace, 2002, Biological consequences of free-radical-damaged DNA bases, Free Radic Biol Med, 33, 1, 10.1016/S0891-5849(02)00827-4 Mahadik, 2001, Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, 25, 463, 10.1016/S0278-5846(00)00181-0 Reddy, 1999, Schizophrenia: Role of oxidative stress and essential fatty acids, 351 Yao, 2001, Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications, CNS Drugs, 15, 287, 10.2165/00023210-200115040-00004 Loven, 1996, Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients, Biol Psychiatry, 40, 230, 10.1016/0006-3223(95)00669-9 Wise, 1974, Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia, J Psychiatr Res, 11, 185, 10.1016/0022-3956(74)90092-2 Klein, 2003, Oxidative stress, cell cycle, and neurodegeneration, J Clin Invest, 111, 785, 10.1172/JCI200318182 Folstein, 1975, Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 Overall, 1962, The Brief Psychiatric Rating Scale, Psychol Rep, 10, 799, 10.2466/pr0.1962.10.3.799 Andreasen, 1984 Andreasen, 1983 Simpson, 1979, A rating scale for tardive dyskinesia, Psychopharmacology, 64, 171, 10.1007/BF00496058 Lawton, 1969, Physical Self-Maintenance Scale (Functional Assessment), Gerontologist, 9, 179, 10.1093/geront/9.3_Part_1.179 Seki, 2002, Immunohistochemical detection of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, in human chronic cholecystitis, Histopathology, 40, 531, 10.1046/j.1365-2559.2002.01415.x Gerdes, 1983, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int J Cancer, 31, 13, 10.1002/ijc.2910310104 Mullen, 1992, NeuN, a neuronal-specific nuclear protein in vertebrates, Development, 116, 201, 10.1242/dev.116.1.201 Szendrei, 1993, Recognition of the minimal epitope of monoclonal antibody tau-1 depends upon the presence of a phosphate group but not its location, J Neurosci Res, 34, 243, 10.1002/jnr.490340212 Schmidt, 1988, Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens, Ann Neurol, 23, 184, 10.1002/ana.410230212 Arai, 1991, Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects, Ann Neurology, 30, 686, 10.1002/ana.410300509 Amaral, 1990, Hippocampal formation, 711 Rosene, 1987, The hippocampal formation of the primate brain: cerebral cortex, 345 Mitchell, 2000, Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment, J Histochem Cytochem, 48, 1627, 10.1177/002215540004801206 Arnold, 1991, The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cerebral Cortex, 1, 103, 10.1093/cercor/1.1.103 Jeste, 1992, Study of neuropathologic changes in the striatum following 4, 8, and 12 months of treatment with fluphenazine in rats, Psychopharmacology (Berl), 106, 154, 10.1007/BF02801966 Cadet, 1990, Chronic treatment with prolixin causes oxidative stress in rat brain, Biol Psychiatry, 28, 738, 10.1016/0006-3223(90)90461-A Mahadik, 1988, Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses, Biol Psychiatry, 24, 199, 10.1016/0006-3223(88)90275-2 Kulkarni, 2003, Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives, Drugs Today (Barc), 39, 19, 10.1358/dot.2003.39.1.799430 Cadet, 1989, Possible involvement of free radicals in neuroleptic-induced movement disorders: evidence from treatment of tardive dyskinesia with Vitamin E, Ann N Y Acad Sci, 570, 176, 10.1111/j.1749-6632.1989.tb14918.x Grima, 2003, Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia, Schizophr Res, 62, 213, 10.1016/S0920-9964(02)00405-X Smythies, 1999, The neurotoxicity of glutamate, dopamine, iron, and reactive oxygen species: functional interrelationships in health and disease: a review-discussion, Neurotoxin Research, 1, 27, 10.1007/BF03033337 Mecocci, 1994, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann Neurol, 36, 747, 10.1002/ana.410360510 de la Monte, 2000, Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease, Lab Invest, 80, 1323, 10.1038/labinvest.3780140 Shigenaga, 1994, Oxidative damage and mitochondrial decay in aging, Proc Natl Acad Sci U S A, 91, 10771, 10.1073/pnas.91.23.10771 Richter, 1995, Oxidative damage to mitochondrial DNA and its relationship to ageing, Int J Biochem Cell Biol, 27, 647, 10.1016/1357-2725(95)00025-K Bandy, 1990, Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?, Free Radic Biol Med, 8, 523, 10.1016/0891-5849(90)90152-9 Middleton, 2002, Gene-expression profiling reveals alterations of specific metabolic pathways in schizophrenia, J Neurosci, 22, 2718, 10.1523/JNEUROSCI.22-07-02718.2002 Kung, 1999, Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study, Synapse, 31, 67, 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-# Uranova, 1989, [Ultrastructure of the synapses of the anterior limbic cortex in schizophrenia], Zh Nevropatol Psikhiatr Im S S Korsakova, 89, 56 Kolomeets, 1999, Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons, Neurosci Behav Physiol, 29, 217, 10.1007/BF02465329 Ben-Shachar, 2002, Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine, J Neurochem, 83, 1241, 10.1046/j.1471-4159.2002.01263.x Gerdes, 1984, Cell-cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J Immunol, 133, 1710, 10.4049/jimmunol.133.4.1710 Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J Cell Physiol, 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 Smith, 1995, Ki-67-immunoreactivity in Alzheimer's disease and other neurodegenerative disorders, J Neuropathol Exp Neurol, 54, 297, 10.1097/00005072-199505000-00002 Yang, 2003, Neuronal cell death is preceded by cell-cycle events at all stages of Alzheimer's disease, J Neurosci, 23, 2557, 10.1523/JNEUROSCI.23-07-02557.2003 Jordan-Sciutto, 2002, Cell-cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis, J Neurosci, 22, 2185, 10.1523/JNEUROSCI.22-06-02185.2002 Smith, 1999, Cell-cycle-related protein expression in vascular dementia and Alzheimer's disease, Neurosci Lett, 271, 45, 10.1016/S0304-3940(99)00509-1 Husseman, 2000, Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases, Neurobiol Aging, 21, 815, 10.1016/S0197-4580(00)00221-9